Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (4,379,890)	$ (7,936,693)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	410	2,942
Stockbased compensation	16,244	2,084,060
Amortization of right of use lease asset		60,825
Foreign currency gain	13,797	(136,211)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	344,056	1,115,261
Accounts payable	(16,727)	214,975
Accrued expenses and other liabilities	1,043,029	(840,380)
Lease liability		(60,108)
Net cash used in operating activities	(2,979,081)	(5,495,329)
Cash flows from financing activities:
Proceeds from issuance of common stock	5,788,918
Common stock issuance costs	(648,928)
Net cash provided by financing activities	5,139,990
Change in cash and cash equivalents	2,160,909	(5,495,329)
Effect of exchange rate changes on cash	48,158	71,051
Cash and cash equivalents-beginning of year	28,786,647	53,076,052
Cash and cash equivalents-end of period	$ 30,995,714	47,651,774
Non-cash investing and financing activities:
Operating lease liabilities arising from obtaining right-of-use assets		$ 123,786